|
GTF2E2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.20410000145921E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.151560E-04 |
| Normal-vs-Stage2 |
1.675430E-03 |
| Normal-vs-Stage3 |
1.70687999999641E-05 |
| Normal-vs-Stage4 |
1.42020000204468E-08 |
| Stage1-vs-Stage2 |
4.518200E-01 |
| Stage1-vs-Stage3 |
3.413400E-01 |
| Stage1-vs-Stage4 |
2.212900E-04 |
| Stage2-vs-Stage3 |
8.543800E-01 |
| Stage2-vs-Stage4 |
1.661990E-02 |
| Stage3-vs-Stage4 |
1.976890E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.8761000026023E-08 |
| Normal-vs-AfricanAmerican |
3.639500E-03 |
| Normal-vs-Asian |
1.150970E-01 |
| Caucasian-vs-AfricanAmerican |
4.243400E-01 |
| Caucasian-vs-Asian |
7.173600E-01 |
| AfricanAmerican-vs-Asian |
9.637400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82470000220647E-08 |
| Normal-vs-Female |
8.10180000000438E-05 |
| Male-vs-Female |
1.205840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.604100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.03409999954829E-07 |
| Normal-vs-Age(61-80Yrs) |
1.33459999995811E-06 |
| Normal-vs-Age(81-100Yrs) |
1.096230E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.737600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.405200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.452400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.829600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.789400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.215800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.222740E-03 |
| Normal-vs-Grade 2 |
4.26519999999764E-05 |
| Normal-vs-Grade 3 |
3.17510000003018E-06 |
| Normal-vs-Grade 4 |
1.04439999981665E-07 |
| Grade 1-vs-Grade 2 |
2.840200E-01 |
| Grade 1-vs-Grade 3 |
4.035400E-01 |
| Grade 1-vs-Grade 4 |
1.836970E-01 |
| Grade 2-vs-Grade 3 |
6.214000E-01 |
| Grade 2-vs-Grade 4 |
1.400450E-03 |
| Grade 3-vs-Grade 4 |
3.244400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.28990000003437E-06 |
| Normal-vs-ccB subtype |
3.31880000004059E-06 |
| ccA subtype-vs-ccB subtype |
5.927000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.14800000020566E-07 |
| Normal-vs-N1 |
1.681440E-03 |
| N0-vs-N1 |
5.506100E-02 |
|
|
